Mutations in the gatB gene as well as mutations in the putative structural gene gatA and the positive acting regulatory gene intA can affect y-amino-ra-butyrate (GABA) transaminase (EC 2.6.1.19) levels in the ascomycete fungus Aspergillus nidulans. Partial or complete loss of function mutations in gatA, gatB and ssuA, which specifies succinic semialdehyde dehydrogenase, can lead to accumulation of w-amino acids resulting in pseudo-constitutivity and elevated expression of (retained) activities under intA control. These regulatory effects underlie selective methods for gatB~, ssuA~ and leaky gatA~ mutations. However, all three gatB-alleles which have been selected lead only to partial loss of GABA transaminase activity as judged by both in vivo and in vitro criteria. It has not been established whether the leakiness of these three ga(Bm utations is an allele-specific or a locus-specific effect and whether or not the GABA transaminase present in gatB~ strains differs from the wild type enzyme. Thus the r61e of the gatB product remains to be elucidated. The gatB gene is not closely linked to any other gene involved in w-amino metabolism or related pathways.
INTRODUCTION
The y-amino-w-butyrate (GABA) transaminase (4-amino-n-butyrate: 2-oxoglutarate aminotransferase, EC 2.6.1.19) of the ascomycete fungus Aspergillus nidulans is principally involved in the catabolism of GABA, /fl-alanine and other w-amino acids (see Fig. 1 ). However, the enzyme can fulfil two other physiological roles: (1) It can substitute for the transaminase which normally catalyses the conversion of N-acetyl-L-glutamic y-semialdehyde to N a -acetyl-L-ornithine for the biosynthesis of L-ornithine (and thence polyamines) and L-arginine (Arst, 1976 ,168 C. R. BAILEY, H. N. ABST, JR AND H. A. PENFOLD 1977 . (2) It can provide an alternative pathway of y?-alanine synthesis, presumably by catalysing the transamination of malonic semialdehyde, for the biosynthesis of coenzyme A (Arst, 1978) .
The regulation of GABA transaminase activity is particularly interesting. Previous work has identified two genes where mutation can affect GABA transaminase levels, the putative structural gene gatA and the positive acting regulatory gene intA (Arst, 1976 , Arst & Bailey, 1977 . The intA gene resembles an integrator gene on the Britten & Davidson (1969) model for regulation of gene expression. GABA transaminase is one of at least four activities specified by genes under intA control. The other three activities are a GABA permease specified by gai>A (Arst, 1976; Bailey, Penfold & Arst, 1979) , acetamidase specified by amdS (Arst,1976; Hynes, 1978; Arst, Penfold & Bailey, 1978) , and an activity necessary (Arst, 1976; Arst et al. 1978) .
for lactam utilisation -probably a lactamase -specified by lamA (Arst et al. 1978) . y?-alanine, GABA, and other w-amino acids act as co-inducers of these four activities. It follows that mutations leading to intracellular accumulation of <y-amino acids may have consequences for the regulation of activities under intA control. In this paper we show that mutations in the gatB gene leading to partial loss of GABA transaminase result in pseudo-constitutivity and elevated expression of (retained) activities under intA control. These regulatory effects underlie selective techniques for gat~B~ mutations, as well as ssuA~ (leading to loss of succinic semialdehyde dehydrogenase) and leaky gatA~ mutations, which also result in w-amino acid accumulation. The main selective technique described in this paper makes use of areA T mutations, which lead to loss of a positive acting regulatory product necessary for the expression of genes subject to nitrogen metabolite (or ammonium) repression (Arst & Cove, 1973; Rand & Arst, 1977) . Reversion of strains carrying areA r mutations has been an extremely fruitful method for obtaining mutations having direct or indirect regulatory effects. One of the reasons for the power of areA* GABA transaminase genes in Aspergillus 169 reversion as a selective technique is the degree to which individual revertants can be characterised in the original areA 1 background. Firstly, suppression of the areA T phenotype can be monitored on a large number of nitrogen sources. Secondly, effects on carbon source utilisation can be screened because, although areA T mutations prevent utilisation of nitrogen sources other than annonium in the presence of carbon catabolite repressing carbon sources such as D-glucose, they do not affect utilisation of any compound as sole carbon source (including those compounds able to serve as nitrogen sources) (Arst & Cove, 1973; Bailey & Arst, 1975; Arst & Bailey, 1977) .
Previous work has shown that regulatory mutations which increase expression of the gab A gene can suppress areA T mutations for utilization of GABA as a nitrogen source (Arst, 1976; Bailey et al. 1979) . These regulatory mutations include creA A mutations leading to carbon catabolite derepression (Arst & Bailey, 1977; Arst, Bailey & Penfold, 1980) , gabl mutations, which are tightly linked to and control in cis the expression of gabA (Bailey et al. 1979) , and intA° mutations leading to constitutive expression of gabA as well as the other activities under intA control (Arst, 1976) . gatB~ mutations, described in this paper, also suppress areA 1 mutations for GABA utilization.
MATERIALS AND METHODS (i) Strains, genetical techniques, and growth tests
A list of A. nidulans mutations studied in this paper is given in Table 1 . Other markers carried by strains are in general use (Clutterbuck, 1974; Clutterbuck & Cove, in the press). gro<A-20 and -21 were isolated as partial suppressors of the arginine or ornithine auxotrophy orn.B-7 in a strain of genotype pantoB-100 (Dpantothenate requiring) fwA-l (fawn conidial colour) orriB-7 after ultraviolet mutagenesis (D. C. Currie, P. F. Searle and H. N. Arst, Jr, unpublished results). The selection medium was a standard minimal medium (Cove, 1966) containing 1 % (w/v) D-glucose as carbon source and 10 mM-ammonium (as the (+ )-tartrate) as nitrogen source and supplemented with (final concentrations) 40 nM-biotin and 15 /iM-D-pantothenate (as the calcium salt), and plates were incubated at 37 °C. Allelism of gatA-20 and -21 to gatA-2 was confirmed by lack of complementation in diploids and tight ( <0-l cm) meiotic linkage. intA~-504 was selected as a partial reversion of the intA~-101 mutation (leading to loss of intA function and noninducibility of activities under intA control) in a strain of genotype biA-l (biotin requiring) intA'-lOl gabI-3 (leading to elevated expression of the GABA permease when in cis) after ultraviolet mutagenesis. The selection medium was standard glucose-minimal medium (Cove, 1966) containing 5 mM GABA as nitrogen source and supplemented with biotin, and the selection temperature was 37 °C. intA~-50i differs from intA-101 in that it does not reduce utilization of GABA, /?-alanine, <J-amino-?i-valerate or acetamide but it remains almost as stringent as intA~-101 in its prevention of 2-pyrrolidone utilization as nitrogen or carbon source. Upon outcrossing to an intA+ strain, no progeny having the intA--101 170 C. R. BAILEY, H. N. ABST, J R AND H. A. PENFOLD phenotype were recovered and it is therefore likely that intA~-504= is a partial intracistronic reversion oi intA-101. The selection of gatA-3, <7a<B-100, -200 and -201, and ssuA-1 is described in the Results section. In each case the glucoseminimal medium described by Cove (1966) was used with supplementation Hynes, 1979 Arst & Cove, 1973 Rand, 1978 ; this work Arst & Cove, 1973; Hynes, 1975 Bailey & Arst, 1975 Arst & Bailey, 1977 Arst, 1976 Bailey etal. 1979 Bailey etal., 1979 Arst, 1976 Penfold, 1979 This work This work This work Arst, 1976; Arst etal. 1978; Bailey et al. 1979 ; this work Arst, 1976; Arst etal. 1978; Bailey et al. 1979 McOully & Forbes (1965) and Clutterbuck (1974) . Growth testing of A. nidulans has been described previously (Arst & Cove, 1969 , 1973 .
Growth tests were carried out by incubating for 2-3 days at 37 °C on standard minimal medium (Cove, 1966) containing appropriate supplements. Unless otherwise specified, 1 % (w/v) D-glucose served as carbon source. When utilization of carbon sources other than glucose was tested, 10 mM-ammonium chloride was used as nitrogen source.
(ii) Enzyme assays
Procedures for growth and extraction of mycelia, assay of GABA transaminase (EC 2.6.1.19) and acetamidase (EC 3.5.1.4), and determination of soluble protein in extracts were those given by Arst et al. (1978) , with the modification that strains carrying mutant areA alleles were grown in media also containing 2 mM-ammonium (as the (+ )-tartrate), which does not appreciably affect enzyme levels. Specific activities of acetamidase are expressed as nmoles ammonium formed per mg soluble protein in extract per minute.
RESULTS (i) The selection of gatB mutations
As described in the Introduction, constitutive intA c mutations suppress oreA r mutations for GABA utilization. It might be predicted that mutations leading to accumulation of co-inducers (w-amino acids or metabolically related compounds) able to interact with the intA+ product to elicit gabA expression would also suppress the areA T phenotype on GABA. A collection of ultraviolet-induced revertants selected as able to utilize 5 ra-GABA as nitrogen source in a strain of genotype pabaA-1 (p-aminobenzoate requiring) areA T -2 was kindly made available to us by Miss D. J. Gorton and Mr R. A. Peel. This collection of mutants enabled the identification of several further classes of mutations able to suppress the areA r phenotype on GABA but recognizably different from previously characterized suppressors (see Introduction) by their diminution of the ability to utilize GABA and its lactam 2-pyrrolidone as carbon sources (see Fig. 1 ). It will be remembered that areA T mutations do not affect the utilization of these compounds as sole carbon sources, so identification of the new supressor mutations was easily made in the areA T -2 background. One of the new suppressor mutations was shown to be a leaky gatA~ allele, designated gatA-3 after linkage and complementation tests. gatA-3 leads to considerable, but not total, loss of GABA transaminase (vide infra). Apparently it allows accumulation of enough GABA (and/or other endogenous w-amino acids) intracellularly for sufficient gabA induction to suppress the areA T mutation yet retains residual GABA transaminase activity to allow GABA to fulfil the nitrogen requirement. gatA-3 is recessive in diploids. Its phenotype is a convincing demonstration that GABA permease, not GABA transaminase, is the activity which limits GABA utilization by areA* strains.
Another suppressor mutation, designated ssuA-l, defines a further class by resulting in inability to utilize 50 mM-y-hydroxy-ra-butyrate (sodium salt) and 172 C. R. BAILEY, H. N. ABST, J R AND H. A. PENFOLD y-butyrolactone as well as GABA and 2-pyrrolidone as carbon sources. This indicates that it probably leads to loss of succinic semialdehyde dehydrogenase (see Fig. 1 ). ssuA-1 strains would thus accumulate succinic semialdehyde which, given the reversability of the GABA transaminase reaction, would result in GABA accumulation with consequent gabA induction. ssuA-1 is also recessive in diploids. GABA and 2-pyrrolidone are inhibitory to ssuA~ strains. This might be due to accumulation of GABA which is toxic (Arst, 1976; Arst et al. 1978 Arst et al. , 1980 Bailey et al. 1979) or to succinic semialdehyde toxicity or to both.
A third new suppressor mutation, also recessive, apparently lowers GABA transaminase levels because it reduces utilization of both 50mM GABA and 2-pyrrolidone as carbon sources (albeit much less drastically than gatA-3) without affecting utilization of y-hydroxy-n.-butyrate or y-butyrolactone. Genetic analysis showed that this mutation, designated gatB-200, identifies a previously unidentified locus because it recombines freely with both intA and gatA mutations. Like gabl mutations (Bailey et al. 1979) , gatA-3 and ssuA-1, ga(B-200 suppresses areA T -2 uniquely for GABA utilization. They are thus unlike truly constitutive intA° mutations which can suppress areA T mutations additionally for utilisation of acetamide and, to a lesser extent, 2-pyrrolidone as nitrogen sources (Arst & Cove, 1973; Arst, 1976; Arst et al. 1978 Arst et al. , 1980 . Nevertheless the methods of selection of two other gatB alleles might indicate an effect on 2-pyrrolidone utilisation. areA r -600 is an extremely leaky areA T allele which has little or no effect on the utilization of most nitrogen sources, including GABA, but does strongly reduce 2-pyrrolidone utilization (Rand, 1978) . Even on 2-pyrrolidone, however, the oreA r -600 phenotype is less extreme than that of nonleaky areA T alleles such as areA T -2. Dr K. N. Rand gave us some ultravioletinduced revertants of a strain of genotype pabaA-1 areA T -600 selected as able to utilize 10 mil 2-pyrrolidone as nitrogen source. Amongst these revertants, we identified strains carrying intA 0 mutations, leaky gatA~ mutations, and a mutation, which, after linkage and complementation analysis, was designated gatB-100. The ability of ga(B~ and leaky gatA~ mutations to suppress areA r -600 on 2-pyrrolidone probably indicates that GABA accumulation can enhance lamA expression.
A different selection method for a gatB~ mutation involved use of a leaky intAã llele. Complete loss of intA function mutations such as intA~-101 are not suppressed for 2-pyrrolidone or GABA utilization by standard gatA~, ssuA~ or gatB~ alleles (Arst, 1976; Arst et al. 1978 and unpublished results) . This is hardly surprising because any regulatory effects of accumulation of GABA or other endogenous w-amino acids must be mediated by a functional intA product. Moreover, 2-pyrrolidone is not itself an inducer of activities under intA control but must be converted to GABA in order to induce (Arst et al. 1978) . The phenotype of the intA~-504 allele is probably best explained as resulting from an intA product which, although functional, has reduced affinity for GABA. It does not significantly affect utilization of GABA or /#-alanine as nitrogen sources but does drastically reduce 2-pyrrolidone utilization. 100 /iM-^-alanine, although too dilute to contribute noticeably to nitrogen nutrition, considerably enhances growth of int A--504: strains on 5 mM-2-pyrrolidone as nitrogen source, presumably by inducing intAmediated expression of lamA and gatA. The growth of in<A~-504 strains on 5 mM-GABA as nitrogen source indicates that relatively high concentrations of GABA achieve sufficient induction in intA~-504: strains whilst exogenous 5 min-2-pyrrolidone cannot maintain sufficiently high internal levels of GABA to induce appreciably. It is also possible that the active form of the in<A~-504 product elicits more efficiently gabA expression, required for GABA but not 2-pyrrolidone utilization, than lamA expression, required for 2-pyrrolidone but not GABA utilization.
After N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis (Alderson & Hartley, 1969) of a strain of genotype yA-2 (yellow conidial colour) intA~-50'i molA-33 (molybdate resistant) pantoB-100 (D-pantothenate requiring), revertants able to utilize 5 mM-2-pyrrolidone as nitrogen source were selected. A common class of revertants, upon outcrossing to a wild type strain, yielded intA + recombinants resembling gatB-200 strains in phenotype. One of these mutations was analysed genetically, found to be tightly linked to gatB-200, and designated gatB-201. The ability of gatB~ mutations to suppress intA~-504: for utilization of 2-pyrrolidone as nitrogen source was confirmed upon construction of gatB-200 intA~-50i double mutants. Another intA~-504: suppressor selected in the same experiment was shown to be an ssuA~ mutation. There were probably also leaky gatA~ mutations responsible for the phenotypes of some revertants, but this was not confirmed. However, gatA-3 intA~-504: double mutants were constructed and found to utilize 2-pyrrolidone as nitrogen source considerably better than in<A~-504 single mutants. Apparently GABA accumulation resulting from gatB~, ssuA or leaky gatA-mutations can overcome the induction defect resulting from i?i<A~-504.
(ii) The phenotype of gatB~ mutations gatB-\00, -200, and -201 have approximately the same phenotype. They reduce utilization of 5 mM-/S-alanine, GABA, <?-amino-n-valerate and 2-pyrrolidone as nitrogen sources but much more drastically reduce utilization of 50 mM-GABA and 2-pyrrolidone as carbon sources. Their reduced utilization of GABA and 2-pyrrolidone is in part a consequence of the toxicity of accumulated GABA (Arst, 1976; Arst et at. 1978 Arst et at. , 1980 Bailey et al. 1979 ) because 50 mM-GABA or 2-pyrrolidone reduces growth in the presence of alternative carbon sources such as 1 % (v/v) ethanol.
gatB-mutations enhance slightly, but less than gatA~ or intA° mutations (Arst, 1976; Hynes, 1978) , utilization of 10 mM-acetamide and acrylamide as nitrogen sources. This suggests an effect on expression of the acetamidase encoded by amdS.
The fact that gatB~ mutations (and leaky gatA~ mutations such as gatA-3) enhance utilization of 5 mM-2-piperidone (#-valerolactam) as nitrogen source suggests an effect on lamA expression also. 2-piperidone, like acrylamide, is a nitrogen source for certain intA c mutants but not for wild type, presumably because it does not result in sufficient induction (Arst et al. 1978) . 100 /iu-fi-174 C. R. BAILEY, H. N. ARST, J R AND H. A. PBKFOLD alanine considerably enhances utilization of 5 mM-2-piperidone and 10 mM-acrylamide as nitrogen sources by wild type strains without itself serving appreciably as a nitrogen source.
The ability of gatB~ mutations to suppress areAF mutations for GABA utilization (see Section (i)) indicates an effect on gab A expression. In this respect gaffi-mutations resemble intA 0 (Arst, 1976) and gabl (Bailey et al. 1979) mutations. Suppression of areA T -2 by gatB-200 for GABA utilization is dependent on a functional gabA allele because gatB-200 gabA-2 areA T -2 triple mutants are unable to use GABA as a nitrogen source.
GABA transaminase activity can also be monitored in vivo using ornB~ strains, which lack the arginine biosynthetic enzyme responsible for the conversion of iV-acetyl-L-glutamic y-semialdehyde to IV^-acetyl-L-ornithine (Arst, 1976 (Arst, , 1977 Arst et al. 1978) . This reaction can apparently also be catalysed by GABA transaminase, and co-inducers such as /?-alanine and GABA can supplement ornBã uxotrophies. intA 0 mutations can suppress ornB~ auxotrophies in double mutants whereas non-leaky intA~ and gatA~ mutations prevent suppression of ornB~ auxotrophies by intA° mutations in triple mutants. gatA-3 behaves similarly to nonleaky gatA~ mutations in this respect. Both gatA-3 ornB-1 double mutants and intA°-2 gatA-3 ornB-1 triple mutants have a requirement for L-arginine or Lornithine, which cannot be replaced by /?-alanine or GABA. Nevertheless, certain leaky gatA~ mutations can partially suppress ornB~ auxotrophies because two, designated gatA-20 and -21, were obtained by reverting an orriB-1 strain to partial prototrophy (H. H. Arst, Jr, D. C. Currie & P. F. Searle, unpublished results. Details are given in Materials and Methods section). The ability of leaky gatAm utations to suppress ornB~ mutations would seem to depend upon their reducing activity towards (leading to the accumulation of) endogenous co-inducers for GABA transaminase such as /?-alanine whilst retaining considerable activity towards iV-acetyl-L-glutamic y-semialdehyde. Reversion of ornB~ strains to prototrophy should be a method for obtaining mutant GABA transaminases with altered substrate specificity. The heterogeneous behaviour of different leaky gatA~ mutations (i.e. gatA-3 v. gatA-20 and -21) in an ornB~ background is preliminary evidence that the putative structural gene gatA codes for the substrate binding site of the enzyme.
Neither gaiB-200 nor ssuA-1 suppresses ornB-1 in corresponding double mutants nor do they affect the ability of /?-alanine or GABA to supplement ornB-1. intA 0 -2 gatB-200 orriB-7 and intA c -2 ssuA-l orriB-7 triple mutants are, like intA c -2 ornB-1 double mutants, prototrophic.
Another in vivo method for monitoring GABA transaminase is afforded by the pantoC-3 mutation, blocking biosynthesis of /?-alanine and hence D-pantothenate and coenzyme A (Arst, 1978) . GABA transaminase can provide an alternative pathway of /?-alanine synthesis, presumably by catalysing the transamination of malonic semialdehyde. Thus intA 0 mutations can suppress the pantoC-3 auxotrophy and co-inducers of GABA transaminase such as DL-/?-aminoisobutyrate can supplement it in strains carrying functional intA and gatA alleles (Arst, 1978) . The sensitivity of this in vivo test is less than that using ornB~ strains because pantoC-3 is itself somewhat leaky. However, in gatB-200pantoG-3 double mutants there is no suppression of the pantoC-3 auxotrophy, and supplementation responses are identical to those of pantoC-3 single mutants.
It was of interest to determine whether the gatB product interacts with either the intA or the gat A product by constructing a series of double mutant strains. The reduced utilization of 2-pyrrolidone, GABA and other &>-amino acids resulting from gro (iii) GABA transaminase levels Data in Table 2 show that whereas gatA~, intA~ and intA c mutations all drastically affect GABA transaminase levels, gra<B-200 has a rather modest effect which is only apparent under strongly inducing conditions. This suggests that the reduced GABA and 2-pyrrolidone utilization due to ga(B~ mutations owes more to the toxicity of non-metabolized GABA (Arst, 1976; Arst et al, 1978 Arst et al, , 1980 Bailey et al. 1979) than to carbon or nitrogen insufficiency. Another example where substrate toxicity makes the in vivo phenotype a sensitive indicator of reductions in enzyme levels is given by Rand & Arst (1977) . Relative activities are expressed as percentages of the specific activity of the wild type strain induced with /0-alanine. tox = toxicity of /?-alanine or GABA to strains of this genotype precludes testing, n.t. = not tested. , and intA c -2 areA'-2 strains all carry the p-aminobenzoate auxotrophy pabaA-1. The wild type, oreA'-2, and oreA-102 strains carry the biotin auxotrophy biA-1. The oreA'-2 and areA-102 strains also cany/mA-l (fawn conidial colour). T -2 strains would suggest that the areA product is involved in control of GABA transaminase. There is also apparently an effect of the areA-102 mutation, which leads to derepressed expression of certain ammonium-repressible activities (Hynes & Pateman, 1970; Arst & Cove, 1973; Hynes, 1975) . However, this effect might be a consequence of enhanced GABA uptake resulting in increased induction (Penfold, 1979) . areA-102 leads to enhanced utilization of a number of a-amino acids (Hynes, 1973a) which in at least two cases is associated with increased uptake (Hynes, 19736; Arst, 1977) . /?-alanine is extremely toxic to areA-102 strains, probably because of increased uptake (Penfold, 1979) , precluding its use as a co-inducer. The uptake of/?-alanine and a-amino acids must involve at least one common step or component because a class of mutation results in inability to utilize a large number of a-amino acids along with /?-alanine and #-amino-7i-valerate (but excluding GABA) and to resistance to a number of toxic amino acid analogues (H. N. Arst Jr, unpublished results). areA-102 would appear to enhance expression of this common step or component because it also enhances utilization of 5 mM-tf-aminow-valerate as a nitrogen source. Moreover, areA-102 gatA-2 double mutants are even more subject to the toxicity of 5 mM-/ff-alanine (in the presence of 1 % (v/v) ethanol as carbon source and 10mM-sodium nitrate as nitrogen source) than areA-102 or gatA-2 single mutants and more subject to the toxicity of 5 mM-5-amino-»-valerate (in the presence of 1 % ethanol as carbon source and 10 musodium nitrate as nitrogen source) than gatA-2 single mutants.
A further point to be noted from Table 2 is that although, by other criteria, gra£B-200 leads to accumulation of w-amino acids, this accumulation appears to be insufficient for constitutive expression of the level of GABA transaminase which it retains. This might indicate that GABA transaminase induction requires higher levels of co-inducer than GABA permease induction (as indicated by ga(Bs uppression of areA r mutations) or acetamidase induction (vide infra). In contrast, intA°-2 clearly leads to constitutive expression of GABA transaminase, provided a functional gatA allele is carried. intA~-l01 is predictably non-inducible. GABA permease activity has not been measured in a gatB~ strain, but it has been shown to be expressed constitutively in a gatA-2 strain (Penfold, 1979) .
(iv) Acetamidase levels Data in Table 3 show that gra<B-200 considerably elevates the uninduced level of acetamidase. This partial constitutivity for acetamidase is an indirect but convincing demonstration that the reduction in GABA transaminase levels is sufficient for a»-amino acids to accumulate. It is responsible for the enhanced acetamide and acrylamide utilization by gaiB~ strains. Partial constitutivity due to a>-amino acid accumulation is also apparent in the ssuA-1 and gatA-2 strains. Hynes (1978) reported partially constitutive synthesis of acetamidase in a gatA-312 strain. Indeed, elevated expression of acetamidase was crucial to the selection of both gatA-312 (Hynes, 1978) and gatA-2 (Arst, 1976) . The uninduced levels of acetami-dase shown in Table 3 correlate well with phenotypes on acetamide-and acrylamidecontaining media: ssuA-l has no effect whilst enhancement of utilization increases in the order gatB-200 < gatA-2 < intA°-2. Decreased /#-alanine catabolism apparently also elevates /?-alanine-induced acetamidase levels in the gatB-200 strain and more markedly in the gatA-2 strain, although the intA c -2 strain exhibits even greater superinducibility. The greater acetamidase levels associated with intA°-2 apparently correlate not only with its effects on acetamide and acrylamide utilization by areA+ strains but also with the fact that it alone of the mutations listed in Table 3 is able to suppress areA T mutations for acetamide utilization. All strains carry the p-aminobenzoate auxotrophy pabaA-l except the intA c -2 and tn<A-101 strains, which carry the biotin auxotrophy biA-1. The ssttA-1 and gra£B-200 strains also carry fwA-l (fawnconidial colour).
(v) Map positions of genes involved in catabolism of GAB A and related compounds
The locations of gatB, ssuA and intA in linkage group II have been reported previously (Arst, 1977; Arst, Rand & Bailey, 1979) . All three genes are located on the right arm of the linkage group, but they recombine freely and are separated by a number of unrelated genes, gat A is located in linkage group VII (Arst, 1976) and a three point cross has established the following linkage relationship (based on 355 progeny analysed):
lamA-5 is tightly linked ( < 1 cM) to/paD-43 in linkage group VIII, but its position in relation to other markers has not been determined. The positions of pacC, where mutations lead to pleiotropic loss of acid phosphatase activity and GABA permease (Arst et al. 1980) , and gabA in linkage group VI have been reported previously (Bailey et al. 1979) . They show only loose linkage and are separated by a number of unrelated genes. The other gene whose expression is known to be under intA control, amdS, is located in linkage group III, where its position 178 C. R. BAILEY, H. N. ARST, J R AND H. A. PENFOLD relative to other markers has been determined (Gunatilleke, Arst & Scazzocchio, 1975; Hynes, 1979) . (Standard linkage maps of A. nidulans are given by Clutterbuck (1974) and Clutter buck & Cove (in the press)). There is thus no clustering of genes involved in catabolism of GABA and related compounds or of genes under intA control.
DISCUSSION
Clearly, mutations in gatB as well as those in gatA and intA' can affect GABA transaminase levels. The complex phenotype of ga(B~ mutants can best be explained in terms of a direct effect on GABA transaminase activity which leads to an intracellular accumulation of w-amino acids. The w-amino acids act as coinducers in the intA~ regulatory system with consequent effects on acetamidase, GABA permease and lactamase activities.
A crucial consideration is whether the three gatB~ alleles selected in this work lead to complete loss of gatB function or whether the selective methods used might require some retention of gatB function, as, for example, the selective methods used to obtain leaky gatA~ alleles do. Clearly, mutations leading to complete loss of GABA transaminase activity will not be selected using the methods described in this paper. An equally important question is whether or not the GABA transaminase present in gafB~ strains is structurally identical to that present in wild type strains. Comparisons of thermolability and kinetic parameters might establish whether gatB codes for a structural component of GABA transaminase. Unfortunately the only assay procedure which seems satisfactory for GABA transaminase in A. nidulans (Arst et al. 1978; Penfold, 1979 ) is cumbersome and ill-suited to kinetic studies.
Present data are compatible with gatB coding for a structural component of GABA transaminase, for a co-factor required for maximal activity, or for some element involved in the regulation of gatA expression. A further question is whether the gatB gene is a fifth gene under intA control. However, an answer to this must await clarification of the role of the gatB product.
Note added in proof. Hynes {Journal of Bacteriology 142, 400-406 (1980) ) has recently questioned the necessity for use of the term integrator gene to describe intA. We believe this terminology to be helpful because it describes an aspect of the'role of intA which is unique amongst characterized positive acting regulatory genes in prokaryotes and lower eukaryotes. In a particular context (i.e. the presence of &t-amino acids), the intA product integrates the expression of one structural gene (i.e. amdS) with that of several others (i.e. gabA, gatA and lamA) whereas in other contexts (i.e. the presence of acetate (or precursors) or benzoate (Arst, 1976; Hynes, 1978) ) that structural gene can be expressed independently. This type of regulatory circuit whereby synthesis of a structural gene product can be induced through the action of any one out of two or more positive acting regulatory genes enables a structural gene to be expressed in as many contexts as there are regulatory genes. Thus the genome need contain only a single copy of the structural gene rather than as many copies as there are contexts in which it is expressed. We believe that no other characterized regulatory gene shares this aspect with intA. For example, although areA is a positive acting regulatory gene which is similarly not metabolic pathway-specific, it does not integrate the expression of structural genes under its control. It could not possibly do so because it mediates repression rather than induction. Indeed, areA can be viewed as the antithesis of an integrator gene because it integrates, if anything, the non-expression of many structural genes in the context of nitrogen-rich growth conditions. Nevertheless, other integrator genes will probably be found (Arst, 1976; Rand, 1978) . It is also possible that, upon further characterization, some of the positive acting regulatory genes mediating induction now considered to be pathwayspecific will turn out to be integrator genes. In addition to references given in the text of this paper, more information about intA is given by Arst in Genetics as a Tool in Microbiology (eds. S. W. Glover and D. Hopwood), Society for General Microbiology Symposium 31, Cambridge University Press, 1981 (in the press).
